Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Company
01 Eisai Limited (4)
Patent
01 2256013 (4)
Product
01 Rufinamide (4)
Dosage
01 Suspension (1)
02 Tablet (2)
03 Tablets (1)
Exp Date
01 2018-08-06 (4)